CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease
Authors:
- A. GreenAGA. Green
- A. LadoganaALA. Ladogana
- N. Cuadrado-CorralesNCN. Cuadrado-Corrales
- R. Sáanchez-ValleRSR. Sáanchez-Valle
- E. MitrováaEME. Mitrováa
- K. StoeckKSK. Stoeck
- T. SklaviadisTST. Sklaviadis
- J. KulczyckiJKJ. Kulczycki
- K. HessKHK. Hess
- M. BodemerMBM. Bodemer
- D. SlivarichováDSD. Slivarichová
- 22 August 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 67 (4) , 637-643
Abstract
Objectives: To analyze the diagnostic sensitivity and specificity of various brain-derived proteins (14-3-3, Tau, neuron specific enolase [NSE], and S100b) in the CSF of patients with Creutzfeldt-Jakob disease (CJD) and to analyze biologic factors that modify these parameters. Methods: CSF was tested for 14-3-3, Tau, NSE, and S100b in 1,859 patients with sporadic, genetic, iatrogenic, and variant CJD, and in 1,117 controls. Results: The highest sensitivity was achieved for 14-3-3 and Tau in sporadic CJD (85% and 86%), and a combined determination of 14-3-3 and Tau, S100b, or NSE increased the sensitivity to over 93%. A multivariate analysis showed that the sensitivity of all tests was highest in patients with the shortest disease duration, age at onset >40 years, and homozygosity at codon 129 of the prion protein gene. In a group of patients with repeated lumbar punctures, a second test also increased the diagnostic sensitivity. Conclusions: The detection of elevated levels of brain-derived proteins in the CSF in patients with suspected Creutzfeldt-Jakob disease is a valuable diagnostic test. A second lumbar puncture may be of value in patients with atypical clinical course in whom the first test was negative.Keywords
This publication has 41 references indexed in Scilit:
- Clinical and genetic features of human prion diseases in Catalonia: 1993–2002European Journal of Neurology, 2004
- A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2003
- Mortality trend from sporadic Creutzfeldt-Jakob disease (CJD) in Italy, 1993–2000Journal of Clinical Epidemiology, 2003
- Coexistence of 21-Hydroxylase and 11β-Hydroxylase Deficiency in Adrenal Incidentalomas and in Subclinical Cushing’s SyndromeHormone Research in Paediatrics, 2002
- Highly increased CSF tau protein and decreased beta-amyloid (1-42) in sporadic CJD: a discrimination from Alzheimer's disease?Journal of Neurology, Neurosurgery & Psychiatry, 2001
- Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2001
- Diagnosis of new variant Creutzfeldt-Jakob diseaseAnnals of Neurology, 2000
- Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjectsAnnals of Neurology, 1999
- Detection of 14‐3‐3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt‐Jakob diseaseAnnals of Neurology, 1998
- Abnormal Proteins in the Cerebrospinal Fluid of Patients with Creutzfeldt–Jakob DiseaseNew England Journal of Medicine, 1986